Patent Assignment
Reel/Frame 053830/0309
Assignment of Assignor's Interest
Recorded: 2020-09-21
Pages: 7
Assignee
CELLA THERAPEUTICS, LLC
6465 SUNSET DRIVE, MIAMI, FLORIDA, 33143
Covered Properties
(2)
Methods for treating glaucoma or ocular hypertension comprising delivery of prostaglandins to the vitreous humour
Drug Delivery Systems Comprising a Neurotrophic Agent, an Apoptosis Signaling Fragment Inhibitor (Fas) or Fas Ligand (Fasl) Inhibitor, a Tumor Necrosis Factor-Alpha (Tnf-Alpha) or Tnf Receptor Inhibitor, a Mitochondrial Peptide, an Oligonucleotide, a Chemokine Inhibitor, or a Cysteine-Aspartic Protease
Application:
62/949,773 →